RenovoRx gets U.S. patent allowance notice for RenovoCath® catheter
RenovoRx (RNXT) receives a notice of allowance for a new U.S. patent covering RenovoCath®, an advanced dual-occlusion catheter for targeted therapeutic drug-delivery in cancer treatment.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.